Will these FTSE-listed stocks be among the biggest winners during the next upturn? These five Fools are confident!
AstraZeneca
What it does: AstraZeneca is a global biopharmaceutical company specialising in oncology, rare diseases, cardiovascular, and other areas.
By Ben McPoland. AstraZeneca (LSE: AZN) is the largest company on the London Stock Exchange with a massive £191bn market cap. Whenever a new bull market gets going, I reckon the pharma firm’s size could help drive a fair bit of it.
The company is aiming to grow its revenue to $80bn between now and 2030. That would represent 75% growth, which would be impressive for an already giant business. It’s also investing in “disruptive innovation that will shape the future of medicine and drive long-term growth”.
As part of this, it recently acquired biotech Fusion Pharmaceuticals for up to $2.4bn, as well as Gracell Biotechnologies, a pioneer in CAR-T…
